FDA Drug Recalls

Recalls / Class II

Class IID-0807-2023

Product

Guaiatussin AC Sugar-Free, Each teaspoonful (5 mL) contains: Guaifenesin (100 mg), Codeine Phosphate (10 mg), Alcohol (3.5% v/v), a) packaged in a) 118 mL bottles, b) 473 mL bottles and c) 100 unit dose cups, Rx Only, Distributed by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs

Affected lot / code info
All Lots

Why it was recalled

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Recalling firm

Firm
Akorn, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5605 Centerpoint Ct Ste A, N/A, Gurnee, Illinois 60031-5278

Distribution

Quantity
N/A
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2023-04-26
FDA classified
2023-06-01
Posted by FDA
2023-06-07
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0807-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls